These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20375592)

  • 1. Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases.
    Corr SC; O'Neill LA
    J Innate Immun; 2009; 1(4):350-7. PubMed ID: 20375592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn.
    Fleer A; Krediet TG
    Neonatology; 2007; 92(3):145-57. PubMed ID: 17476116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor polymorphisms and susceptibility to human disease.
    Misch EA; Hawn TR
    Clin Sci (Lond); 2008 Mar; 114(5):347-60. PubMed ID: 18230059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How important are Toll-like receptors for antimicrobial responses?
    Carpenter S; O'Neill LA
    Cell Microbiol; 2007 Aug; 9(8):1891-901. PubMed ID: 17521328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations in toll-like receptor pathway genes influence asthma and atopy.
    Tesse R; Pandey RC; Kabesch M
    Allergy; 2011 Mar; 66(3):307-16. PubMed ID: 21039600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the regulation of signalling by toll-like receptors and nod-like receptors.
    Coll RC; O'Neill LA
    J Innate Immun; 2010; 2(5):406-21. PubMed ID: 20505309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.
    Ragnarsdóttir B; Fischer H; Godaly G; Grönberg-Hernandez J; Gustafsson M; Karpman D; Lundstedt AC; Lutay N; Rämisch S; Svensson ML; Wullt B; Yadav M; Svanborg C
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():12-20. PubMed ID: 18826477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrosequencing of toll-like receptor polymorphisms of functional relevance.
    Ahmad-Nejad P
    Methods Mol Biol; 2009; 496():73-87. PubMed ID: 18839106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria.
    Mockenhaupt FP; Cramer JP; Hamann L; Stegemann MS; Eckert J; Oh NR; Otchwemah RN; Dietz E; Ehrhardt S; Schröder NW; Bienzle U; Schumann RR
    J Commun Dis; 2006 Mar; 38(3):230-45. PubMed ID: 17373355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in innate immunity pathways and their potential contribution to the SIRS/CARS debate: evidence from human studies and animal models.
    Kumpf O; Schumann RR
    J Innate Immun; 2010; 2(5):381-94. PubMed ID: 20431282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonic saline enhances host defense to bacterial challenge by augmenting Toll-like receptors.
    Chen LW; Huang HL; Lee IT; Hsu CM; Lu PJ
    Crit Care Med; 2006 Jun; 34(6):1758-68. PubMed ID: 16625117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. paratuberculosis infection in cattle.
    Mucha R; Bhide MR; Chakurkar EB; Novak M; Mikula I
    Vet Immunol Immunopathol; 2009 Apr; 128(4):381-8. PubMed ID: 19131114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor signalling and the clinical benefits that lie within.
    Verstak B; Hertzog P; Mansell A
    Inflamm Res; 2007 Jan; 56(1):1-10. PubMed ID: 17334664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors as targets for immune disorders.
    Keogh B; Parker AE
    Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
    Frantz S; Ertl G; Bauersachs J
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors.
    Ryffel B; Fremond C; Jacobs M; Parida S; Botha T; Schnyder B; Quesniaux V
    Tuberculosis (Edinb); 2005; 85(5-6):395-405. PubMed ID: 16257265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.